Phoenix Convention Center
Miltenyi Biotec booth #907
November 4–8 | Phoenix, Arizona, USA
Miltenyi Biotec will be present at the 41st Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2026), the world's largest cancer immunotherapy conference, where the community comes together to share scientific insights, build new connections, and shape the future of the field.
Visit us at booth #907 to explore our latest innovations and discuss how we can work together to advance cancer research and translate discoveries into new therapeutic possibilities. To find out more about what we have prepared for you, check our full program below. We look forward to meeting you in Phoenix!
Phoenix Convention Center
Miltenyi Biotec booth #907
November 6–7 | Exhibit hall dates and hours (MT)
Friday, November 6
10:00 a.m.–2:00 p.m. | 5:00–7:00 p.m.
Saturday, November 7
10:00 a.m.–2:00 p.m. | 6:00–8:10 p.m.
Spatial biology enables detailed analysis of molecular processes within native tissue architecture. Using MACSima® Imaging Cycling Staining (MICS), hundreds of proteins and dozens of RNA markers can be detected on the same section, generating high-dimensional datasets that enhance cellular characterization and improve therapeutic target selection.
Join our Tech Talk and discover how Vicinity Bio applies the MACSima Platform within its end-to-end spatial biology workflow, combining high-multiplex imaging with AI-supported analysis and expert pathology to transform tissue sections into high-dimensional data and actionable insights for research and clinical applications.
Friday, November 6
6:05–6:20 p.m. (MT)
North Building | Lower Level
Exhibit Hall Presentation Stage
Ana Cristina Costa Veloso, PhD
Product Manager Imaging Instruments & Reagents, Miltenyi Biotec | Germany
Ana Veloso studied Biochemistry and Health Sciences before receiving her PhD in Molecular Biology from Humboldt University of Berlin, Germany, where her research focused on single-cell sequencing and data analysis. Her industry experience includes product management at a sequencing start-up. She joined Miltenyi Biotec in 2023 as a Product Manager focused on developing new solutions for spatial biology.
Kilian Wistuba-Hamprecht, PhD
CEO, Vicinity Bio | Research Group Leader, DKFZ | Germany
Kilian Wistuba-Hamprecht is CEO and Co-Founder of Vicinity Bio, as well as Group Leader of the “Skin Cancer Unit” of the German Cancer Research Center (DKFZ) in Heidelberg, Germany.
Have fun, discover our solutions in spatial biology, tumor dissociation, cell isolation, and cell manufacturing, and win a prize!
Friday, November 6
12:15–1:45 p.m. | 5:30–7:00 p.m. (MT)
#77
A new spatial multiomics platform using in situ RNA sequencing-by-synthesis and
protein co-detection for TCR clonality and phenotype profiling on clinical FFPE samples
Dongju Park
#171
Development and characterization of an inducible cytokine armored prostate-specific
membrane antigen (PSMA)-targeting CAR T cell against prostate cancer models
Soumyadeep Dey
#181
Combinatorial targeting of ovarian cancer using PRAME-specific TCR T cells and an
inducible IL-18-armored FolR1 CAR T cell
Arunakumar Gangaplara
#209
Novel BCMA/GPRC5D dual-targeting CAR T cells mitigate antigen escape with a favorable safety profile for multiple myeloma
Kun Luo
#577
Biopsy-associated tumor regression in late relapsed DLBCL after tandem CD20-CD19 CAR T cell therapy
Kevin Christmas
Saturday, November 7
12:15–1:45 p.m. | 6:40–8:10 p.m. (MT)
#174
TEM8-driven synNotch CAR T cells enable tumor-selective targeting of pancreatic cancer
Nidhi Dwivedi
Do you want to get in contact with us? Send your inquiry to:
Maximilian Büttner, PhD | Product Manager Imaging Reagents
You have previously chosen International as your location.
What do you want to do?